Back to Results
First PageMeta Content
Pharmascience / Cancer research / Prostate cancer / Immune system / Metastasis / Breast cancer / Medicine / Immunology / Ribbon symbolism


NEWS RELEASE REDX PHARMA AND PHARMASCIENCE ENTER INTO LICENSE AGREEMENT FOR cFMS CANCER PROGRAM Liverpool, UK and Montreal, Canada, May 2nd, [removed]The early stage drug development
Add to Reading List

Document Date: 2013-05-08 08:05:11

Open Document

File Size: 128,78 KB

Share Result on Facebook

City

Montreal / Liverpool / /

Company

Pharmascience International / Pharmascience Inc. / Redx Pharma / Redx Pharma Redx Pharma / Pharmascience Canada / Aegera Therapeutics / /

Country

Canada / United Kingdom / /

Currency

pence / /

/

Event

Business Partnership / FDA Phase / M&A / /

IndustryTerm

pharmaceutical company developing new drug candidates / pharmaceutical / /

MedicalCondition

cancer / tumour / target cancer / kill cancers / Bone metastases / several major cancers / metastatic cancer / breast and prostate cancer / tumours / /

Person

Neil Murray / Mathieu Boudreau / Ruth Cobban / Chris Hulme / /

/

Position

Director of Corporate Affairs and Communications sletendre@pharmascience.com / Director / Business Development & Strategic Planning mathieuboudreau@pharmascience.com / chief executive / Director of Business Development and Strategic Planning / /

Product

Redox Switch™ platform / Redox Switch™ / AEG40826 / /

Technology

pharmacokinetics / drug discovery / drug development / /

SocialTag